Aqr Capital Management LLC Concert Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $149,766 - $196,066	-47,245 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $90,457 - $125,728	-23,994 Reduced 33.68%	47,245 $199,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $346,221 - $931,093	71,239 New	71,239 $355,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $81,615 - $178,652	-13,648 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $77,930 - $125,834	13,648 New	13,648 $126,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $238,265 - $331,148	-25,240 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$12.07 - $17.54 $1.2 Million - $1.74 Million	-99,154 Reduced 79.71%	25,240 $305,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $1.35 Million - $1.94 Million	-119,687 Reduced 49.04%	124,394 $1.56 Million
Q3 2018 Nov 15, 2018	SELL	$12.82 - $17.88 $321,871 - $448,913	-25,107 Reduced 9.33%	244,081 $3.62 Million
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $2 Million - $2.57 Million	-118,560 Reduced 30.58%	269,188 $4.53 Million
Q1 2018 May 15, 2018	BUY	$19.24 - $28.03 $4.33 Million - $6.31 Million	225,009 Added 138.26%	387,748 $8.88 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $2.27 Million - $4.73 Million	162,739	162,739 $4.21 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.